Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient

<h3>Background</h3><p dir="ltr">Vaccines were developed and deployed to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to characterize patterns in the protection provided by the BNT162b2 and mRNA-1273 mRNA vaccines against...

Full description

Saved in:
Bibliographic Details
Main Author: Layan Sukik (6619544) (author)
Other Authors: Hiam Chemaitelly (439114) (author), Houssein H. Ayoub (9262512) (author), Peter Coyle (787159) (author), Patrick Tang (239534) (author), Hadi M. Yassine (4675846) (author), Asmaa A. Al Thani (10494576) (author), Mohammad R. Hasan (13777597) (author), Zaina Al-Kanaani (4557205) (author), Einas Al-Kuwari (13777606) (author), Andrew Jeremijenko (11506565) (author), Anvar Hassan Kaleeckal (11847034) (author), Ali Nizar Latif (11570540) (author), Riyazuddin Mohammad Shaik (11847037) (author), Hanan F. Abdul-Rahim (13777600) (author), Gheyath K. Nasrallah (9200525) (author), Mohamed Ghaith Al-Kuwari (4264192) (author), Adeel A. Butt (3697705) (author), Hamad Eid Al-Romaihi (6837251) (author), Mohamed H. Al-Thani (11847049) (author), Abdullatif Al-Khal (11721410) (author), Roberto Bertollini (9538620) (author), Manar E. Abdel-Rahman (5593553) (author), Laith J. Abu-Raddad (9262524) (author)
Published: 2024
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!